CAS: 875337-44-3 - N-[(3-fluoro-4-{[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)carbamothioyl]-2-phenylacetamide

Formel: C₂₆H₂₀FN₅O₂S₂

InChl: InChI=1/C26H20FN5O2S2/c1-32-14-20(29-15-32)23-13-19-25(36-23)22(9-10-28-19)34-21-8-7-17(12-18(21)27)30-26(35)31-24(33)11-16-5-3-2-4-6-16/h2-10,12-15H,11H2,1H3,(H2,30,31,33,35)

Synonyme:

• Mgcd-265

N-[[[3-Fluoro-4-[[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]benzeneacetamide

CAS: 875337-44-3

• Formel: C₂₆H₂₀FN₅O₂S₂
• Reinheit: %
• Farbe und Form: Solid
• Molekulargewicht: 517.5977

MGCD-265 analog

CAS: 875337-44-3

Glesatinib, an oral tyrosine kinase inhibitor, targets c-Met and VEGFR2 with IC50s of 29 nM …

• Formel: C₂₆H₂₀FN₅O₂S₂
• Reinheit: 98.06% - 98.68%
• Farbe und Form: Solid
• Molekulargewicht: 517.6

MGCD 265

CAS: 875337-44-3

Inhibits MET, VEGFR1-3, Tie and Ron tyrosine kinases; antineoplastic

• Formel: C₂₆H₂₀FN₅O₂S₂
• Reinheit: Min. 95%
• Molekulargewicht: 517.60 g/mol

MGCD-265

CAS: 875337-44-3

• Formel: C₂₆H₂₀FN₅O₂S₂
• Farbe und Form: Neat
• Molekulargewicht: 517.598